Medication info
Tutoposic 10/160 Milligrams

Tutoposic 10/160 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Korea Chorus Co., Ltd.
Appearance
Bright yellow, rectangular film-coated tablets
Packaging
30 tablets/box [(10 tablets/Alu-Alu x 3)]
Approval status
Active

MFDS item code 201603717 · Approved 2016.06.21 · Insurance code 647204190

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take this medicine at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg as monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg as monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg as monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Korea Chorus Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively lower blood pressure and improve hypertension in patients with essential hypertension who do not achieve sufficient blood pressure control with monotherapy using either amlodipine or valsartan.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take this medicine at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg as monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg as monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg as monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to this medication or similar drugs, pregnant or nursing women, patients with severe kidney or liver disease, and patients with certain heart diseases should not take this medication. Patients with sodium or fluid deficiency should correct their condition before taking this medication, and blood pressure and condition should be closely monitored during treatment. Patients with high potassium levels or taking medications that may increase potassium should have their potassium levels frequently checked. Patients with renal vascular issues or who have recently undergone kidney transplantation need to exercise caution when taking this medication, as it may worsen kidney function. If symptoms of angioedema such as swelling of the face, lips, or tongue occur while taking this medication, it should be stopped immediately and should not be reused. Patients with heart failure or those recovering from myocardial infarction require regular kidney function tests due to the risk of changes in kidney function and hypotension when using this medication. Patients with acute myocardial infarction or certain heart valve diseases should be cautious with this medication due to the potential for worsening angina or heart problems. This medication may increase the risk of hypotension, worsening kidney function, and hyperkalemia when taken with other RAAS medications, so concurrent use should be avoided or blood pressure and kidney function should be frequently monitored. Caution is advised when driving or operating machinery, as dizziness or fatigue may occur. Overdose may cause severe hypotension or heart problems, so any unusual symptoms should be reported to a healthcare professional immediately. Regular tests, including liver and kidney function tests, are recommended during treatment with this medication. Older adults can take a dosage similar to that of general adults, but should follow medical guidance based on their condition. This medication is not recommended for children as safety and efficacy in pediatric patients under 18 years of age have not been established.

Side effects

  • Nasopharyngitis
  • influenza
  • hypersensitivity
  • visual disturbance
  • anxiety
  • headache
  • dizziness
  • drowsiness
  • positional dizziness
  • paresthesia
Show 115 more
  • vertigo
  • tinnitus
  • tachycardia
  • palpitations
  • syncope
  • orthostatic hypotension
  • hypotension
  • cough
  • pain in the pharynx and larynx
  • diarrhea
  • nausea
  • abdominal pain
  • constipation
  • thirst
  • rash
  • erythema
  • hyperhidrosis
  • pruritus
  • joint swelling
  • low back pain
  • arthritis
  • muscle cramps
  • weakness
  • polyuria
  • nocturia
  • erectile dysfunction
  • edema
  • ankle edema
  • facial edema
  • peripheral edema
  • fatigue
  • flushing
  • asthenia
  • facial flushing
  • decreased hemoglobin
  • decreased hematocrit
  • neutropenia
  • thrombocytopenia
  • serum sickness
  • increased serum potassium
  • vasculitis
  • elevated liver function tests
  • angioedema
  • myalgia
  • renal failure
  • kidney damage
  • increased serum creatinine
  • insomnia
  • decreased libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory tract infection
  • viral infection
  • diplopia
  • thrombocytopenic purpura
  • leukopenia
  • allergic reaction
  • hyperglycemia
  • insomnia
  • mood changes
  • tremors
  • sensory impairment
  • taste disturbance
  • peripheral neuropathy
  • excessive muscle tension
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • myocardial infarction
  • vasculitis
  • dyspnea
  • rhinitis
  • vomiting
  • dyspepsia
  • pancreatitis
  • gastritis
  • gingival hyperplasia
  • hepatitis
  • jaundice
  • alopecia
  • purpura
  • skin depigmentation
  • photosensitivity reaction
  • angioedema
  • urticaria
  • erythema multiforme
  • Stevens-Johnson syndrome
  • myalgia
  • urinary disorders
  • enuresis
  • gynecomastia
  • pain
  • malaise
  • chest pain
  • weight loss
  • weight gain
  • increased liver enzymes
  • chest discomfort
  • abdominal discomfort
  • gastroesophageal reflux
  • neck pain
  • hypercholesterolemia
  • hypoglycemia
  • nervousness
  • Stevens-Johnson syndrome
  • pruritus
  • peripheral edema
  • hypotension
  • edema
  • chest pain
  • pain
  • cough
  • nocturia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is best to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

Bright yellow, rectangular film-coated tablets

Package unit

30 tablets/box [(10 tablets/Alu-Alu x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.